Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 Opinion of Stradling Yocca Carlson & Rauth
- 23.1 Consent of Grant Thornton LLP
- 23.2 Consent of Bdo Seidman, LLP
- 23.3 Consent of Pricewaterhousecoopers LLP
- 99.2 Consent of MTS Securities, LLC
- 99.3 Form of Neurogen Proxy Card
LGND similar filings
- 17 Dec 09 Registration of securities issued in business combination transactions (amended)
- 25 Nov 09 Registration of securities issued in business combination transactions
- 6 Nov 09 Registration of securities issued in business combination transactions (amended)
- 30 Sep 09 Registration of securities issued in business combination transactions
- 17 Nov 08 Registration of securities issued in business combination transactions (amended)
- 20 Oct 08 Registration of securities issued in business combination transactions
- 9 Jul 98 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-4 of Ligand Pharmaceuticals Incorporated of our report dated March 31, 2009 relating to the financial statements, which appears in Neurogen Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Hartford, Connecticut
September 30, 2009